Advertisement

Topics

Search Results for "E7389 Breast Cancer"

14:30 EDT 28th May 2017 | BioPortfolio

Matching Channels

Epithelial cell adhesion molecule EpCAM CD326

Epithelial cell adhesion molecule (EpCAM; CD326) is a cell surface protein that is frequently expressed at high level on most solid tumor types, including prostate, breast, colon, gastric, ovarian, ...

Selective Estrogen Receptor Modulators SERMs

Selective estrogen receptor modulators (SERMs) act as estrogen receptor (ER) agonists or antagonist depending on the targeted tissue and the specific configuration of the used SERM. Effects on bone, e...

Breast Lumps

Mastalgia Breast Pain

Breast Implants - Augmentation

Breast implants are medical devices that are used to augment breast size or to reconstruct the breast following mastectomy or to correct a congenital abnormality. Breast implants consist of a silico...

Matching News

Brain metastases of breast cancer rely on cellular cloak

Ninety percent of cancer deaths are from cancer spread. Breast cancer patients, for example, typically do not die because cancer returns in their breast, they die because it spreads to other parts of...

How 'cannibalism' by breast cancer cells promotes dormancy: A possible clue into cancer recurrence

Breast cancer death rates overall have steadily declined since 1989, leading to an increased number of survivors. But while breast cancer survivors are grateful their bodies show no trace of the disea...

Cancer: How fat boosts breast cancer

A molecule made by fat cells in human breast tissue increases the growth of certain breast-cancer cells. The finding suggests a potential reason why larger breast size seems to correlate with a higher...

More Women With Breast Cancer Opt to Remove Healthy Breast

One in three breast cancer patients under 45 in 2012 removed the healthy breast along with the breast affected by cancer, a new study found.

Some early breast cancer patients benefit more from breast conservation than from mastectomy

(ECCO-the European CanCer Organisation) Breast conserving therapy (BCT) is better than mastectomy for patients with some types of early breast cancer, according to results from the largest study to d...

Advanced Triple-Negative Breast Cancer

Sacituzumab govetecan also known as IMMU-132 has received Breakthrough Therapy Designation from the U.S. Food and Drug Administration (FDA) for the treatment of patients with triple-negative breast ca...

Researchers discover how breast cancer spreads to the brain

Ninety percent of cancer deaths are from cancer spread. Breast cancer patients, for example, typically do not die because cancer returns in their breast, they die because it spreads to other parts of ...

Soy food consumption linked to prolonged survival in some breast cancer patients

(Wiley) New research indicates that dietary soy products are safe and even beneficial for women diagnosed with breast cancer. Published early online in CANCER, a peer-reviewed journal of the American ...

Matching PubMed Articles

Metastatic Breast Cancer.

Despite advances in breast cancer screening, diagnosis, and treatment, nearly 12% of patients with a diagnosis of breast cancer eventually develop metastatic disease, or breast cancer that has spread ...

Relationship of Predicted Risk of Developing Invasive Breast Cancer, as Assessed with Three Models, and Breast Cancer Mortality among Breast Cancer Patients.

Breast cancer risk prediction models are used to plan clinical trials and counsel women; however, relationships of predicted risks of breast cancer incidence and prognosis after breast cancer diagnosi...

Breast cancer: updates and advances in 2016.

Approximately 1 in 8 US women (12%) will develop invasive breast cancer over the course of her lifetime. In 2016, an estimated 246,660 new cases of invasive breast cancer are expected to be diagnosed ...

Metaplastic Breast Cancer: Molecular Typing and Identification of Potential Targeted Therapies at a Single Institution.

Metaplastic breast carcinoma (MBC) is a rare and aggressive histologic subtype of breast cancer comprising approximately 0.5% to 5.0% of all invasive breast cancers with a poor prognosis and limited t...

Prohibitin promotes androgen receptor activation in ER-positive breast cancer.

Prohibitin (PHB) is an evolutionarily conserved protein with multiple functions in both normal and cancer cells. Androgen receptor (AR) was reported to act as a different role in the ER-positive and E...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement